L. V. van Vlerken

Vitamin K deficiency bleeding in cholestatic infants with alpha-1-antitrypsin deficiency

T. D. de Koning, P. V. van Hasselt, K. Kok, 2009, Archives of Disease in Childhood: Fetal and Neonatal Edition.

Ribavirin rather than PEG‐interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients

P. Siersema, J. Drenth, K. V. van Erpecum, 2012, Journal of viral hepatitis.

Measuring Ribavirin Concentrations During the Earliest Stages of Antiviral Therapy for Hepatitis C: Potential Relevance for Treatment Outcome

P. Siersema, J. Drenth, K. V. van Erpecum, 2013, Therapeutic drug monitoring.

Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability

P. Siersema, F. D. de Rooij, K. V. van Erpecum, 2012, European journal of clinical investigation.

Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review.

Peter D Siersema, P. Siersema, K. V. van Erpecum, 2013, Annals of hepatology.

Real life adherence of chronic hepatitis B patients to entecavir treatment.

P. Siersema, H. Janssen, K. V. van Erpecum, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Adherence to ribavirin in chronic hepatitis C patients on antiviral treatment: Results from a randomized controlled trial using real-time medication monitoring.

P. Siersema, K. V. van Erpecum, G. Koek, 2016, Clinics and research in hepatology and gastroenterology.

Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment

P. Siersema, J. Drenth, K. V. van Erpecum, 2010, European journal of gastroenterology & hepatology.